Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.

Subjects

Subjects :

Humans
Male
Female
Neoplasms, Second Primary etiology
Neoplasms, Second Primary therapy
Adult
Receptors, Chimeric Antigen
Middle Aged
Neoplasms therapy
Neoplasms immunology
Antigens, CD19 immunology
Immunotherapy, Adoptive methods
Immunotherapy, Adoptive adverse effects

Details

Language :

English

ISSN :

2473-9537

Volume :

8

Issue :

10

Database :

MEDLINE

Journal :

Blood advances

Publication Type :

Academic Journal

Accession number :

38498727

Full Text :

https://doi.org/10.1182/bloodadvances.2024012573